Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Monday reported a second-quarter loss of $56.4 million, after reporting a profit in the same period a year earlier.
The Gaithersburg, Maryland-based company said it had a loss of $1.13 per share. Losses, adjusted for non-recurring costs, came to 86 cents per share.
The biopharmaceutical company posted revenue of $242.7 million in the period.
Emergent Biosolutions expects full-year revenue in the range of $1.15 billion to...
Emergent Biosolutions expects full-year revenue in the range of $1.15 billion to $1.25 billion.
Insight by Contrast Security: During this exclusive webinar, moderator Jared Serbu and agency leaders discuss software implementation cyber risks and how they are measuring and mitigating those risks in their software ecosystem and supply chain. Register now!
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
© 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.